Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

por Angela Horvath, Florian Rainer, Mina Bashir, Bettina Leber, Bianca Schmerboeck, Ingeborg Klymiuk, Andrea Groselj-Strele, Marija Durdevic, Daniel E. Freedberg, Julian A. Abrams, Peter Fickert, Philipp Stiegler, Vanessa Stadlbauer
Publicado 2019

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients

por Christoph Jüngst, Vanessa Stadlbauer, Matthias C. Reichert, Vincent Zimmer, Susanne N. Weber, Lisa Ofner-Ziegenfuß, Torsten Voigtländer, Walter Spindelböck, Peter Fickert, Gabriele I. Kirchner, Frank Lammert, Tim O. Lankisch, Marcin Krawczyk
Publicado 2017